Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.

অনুরূপ উপাদানগুলি

• Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup symptom benefit study.
  অনুযায়ী: Friedlander, M, অন্যান্য
  প্রকাশিত: (2014)
• Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study.
  অনুযায়ী: Sjoquist, K, অন্যান্য
  প্রকাশিত: (2013)
• The importance of patient-reported outcomes in clinical trials and strategies for future optimization
  অনুযায়ী: Mercieca-Bebber R, অন্যান্য
  প্রকাশিত: (2018-11-01)
• Patient-Reported Outcomes in Ovarian Cancer: Facilitating and Enhancing the Reporting of Symptoms, Adverse Events, and Subjective Benefit of Treatment in Clinical Trials and Clinical Practice
  অনুযায়ী: Campbell R, অন্যান্য
  প্রকাশিত: (2023-05-01)
• Symptoms Relevant to Surveillance for Ovarian Cancer
  অনুযায়ী: Robert M. Ore, অন্যান্য
  প্রকাশিত: (2017-03-01)